Every year, half a million children under five die of diarrhoea globally — but doctors and pharmacists often don’t prescribe a cheap lifesaving treatment for the condition https://t.co/WIMjlcMOaR
Virtual wards are being used in the NHS with support from the HTA Lab at NICE. A really interesting alternative to physical NHS care.
https://t.co/cXXiS7oKxR
Hot off the press! A review by infectious disease experts addressing the value and implementation of rapid diagnostic tests in antimicrobial stewardship across low-to-middle and high income countries (open access) https://t.co/6WFA08KhMx
This article analyses the clinical development times of innovative drugs, including trends for therapeutic areas and and molecule types ICYMI https://t.co/wszdUuKKNN
In order for Europe to benefit from breakthroughs in precision oncology, it’s essential that HTA bodies expand their capacity to use and accept data generated via novel clinical trials designs. Find out more: https://t.co/wPO9pgsDfM
#WeWontRest
Don't miss out! Yesterday, our experts moderated a @networkpharma webinar on 'the digital payer - fact or fiction?'. Click here to view the recording! #DigitalPayer#MedComms https://t.co/bpsJvFdP8J
Delivery of confirmatory studies following any accelerated approval has been an area of growth and contention. Our Prime Access team takes a closer look!
https://t.co/S8gCzXxQRR
Check out some great examples of digitialised #marketaccess deliverables below. Our Prime Access team discuss how to optimise #payerengagement planning through use of digital media in their white paper. For the full article, click here! https://t.co/xDvPGgUqdV #MedComms#Payer
New Cell & Gene Therapy Collective featuring @BMSnews, @AstellasEurope and @Novartis seeks to boost adoption of these innovative therapies in the UK https://t.co/VOcFPyisu7 #pharma#celltherapy#genetherapy
Health workers who deliver essential services are at their lowest density in the places where the highest burden of disease was measured. The world needs millions more of them if it is to achieve universal health coverage by 2030. https://t.co/xqoPlm77p5
Are you looking to start your #career and wondering what it's like to work in the world of #medcomms? You can check out more quotes like Cecilia's by reading the 'MedComms Careers Guide: getting started in medical communications' here https://t.co/iaHRJk8TtC #PrimeGlobalPeople
Immune cell (yellow) fights a highly aggressive cancer cell (magenta) every time immune cell attacks 👊 there is a white flash. enjoy the fight 😄 Credit-Jeroen Slaats
Our paper about the role of off-patent medicines in cancer care: #biosimilar use, competition and sustainability are at the core https://t.co/vk0CGiDBjc #BIOS21